Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6008457 | 0.82 | EGLN1 (0.39) | TDP1SMN1; SMN2SLC22A6FOLH1 | |
| SCHEMBL6863765 | 0.80 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6FOLH1 | |
| SCHEMBL11094949 | 0.80 | ALOX15 (0.35) | TDP1SMN1; SMN2SLC22A6 | |
| SCHEMBL2590042 | 0.78 | TDP1 (0.39) | TDP1SMN1; SMN2SLC22A6LDHASRR | |
| SCHEMBL5404107 | 0.77 | ALOX15 (0.38) | TDP1SMN1; SMN2SLC22A6FOLH1 | |
| SCHEMBL8812874 | 0.75 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6FOLH1 | |
| SCHEMBL895686 | 0.73 | TSHR (0.39) | TDP1SMN1; SMN2SLC22A6 | |
| SCHEMBL1828772 | 0.73 | ALOX15 (0.36) | TDP1SMN1; SMN2SLC22A6 | |
| Bicarbonate SCHEMBL6393528 | 0.73 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6FOLH1 | |
| SCHEMBL9053647 | 0.72 | TDP1 (0.46) | TDP1SMN1; SMN2SLC22A6SRRFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9295426-B2 | Detection of a physiologic parameter with a probe | EXOSTAT MEDICAL, INC. (US) | 2016-03-29 | — | — | US | claimed |
| US-8996090-B2 | Noninvasive detection of a physiologic parameter within a body tissue of a patient | EXOSTAT MEDICAL, INC. (US) | 2015-03-31 | — | — | US | claimed |
| US-20140322779-A1 | EUKARYOTIC ORGANISMS AND METHODS FOR INCREASING THE AVAILABILITY OF CYTOSOLIC ACETYL-COA, AND FOR THE PRODUCING 1,3-BUTANEDIOL | GENOMATICA, INC. | 2014-10-30 | — | — | US | claimed |
| US-20130066035-A1 | EUKARYOTIC ORGANISMS AND METHODS FOR INCREASING THE AVAILABILITY OF CYTOSOLIC ACETYL-COA, AND FOR PRODUCING 1,3-BUTANEDIOL | GENOMATICA, INC. (US) | 2013-03-14 | — | — | US | claimed |
| US-20110152646-A1 | NONINVASIVE DETECTION OF A PHYSIOLOGIC PARAMETER WITH A PROBE | Vasamed Inc. (US) | 2011-06-23 | — | — | US | claimed |
| EP-1534123-A4 | NONINVASIVE DETECTION OF A PHYSIOLOGIC PARAMETER WITHIN A BODY TISSUE OF A PATIENT | OPTICAL SENSORS INC (US) | 2006-11-22 | — | — | EP | claimed |
| US-20060020179-A1 | Noninvasive detection of a physiologic parameter with a probe | OPTICAL SENSORS, INC. (US) | 2006-01-26 | — | — | US | claimed |
| JP-2005528156-A | — | — | 2005-09-22 | — | — | JP | claimed |
| EP-1534123-A2 | NONINVASIVE DETECTION OF A PHYSIOLOGIC PARAMETER WITHIN A BODY TISSUE OF A PATIENT | Optical Sensors Inc. (US) | 2005-06-01 | — | — | EP | claimed |
| US-20040006263-A1 | Noninvasive detection of a physiologic parameter within a body tissue of a patient | EXOSTAT MEDICAL, INC. | 2004-01-08 | — | — | US | claimed |
| WO-2003101277-A2 | NONINVASIVE DETECTION OF A PHYSIOLOGIC PARAMETER WITHIN A BODY TISSUE OF A PATIENT | OPTICAL SENSORS INCORPORATED (US) | 2003-12-11 | — | — | WO | claimed |
| CN-118341461-A | Nitrogen-doped carbon double-enzyme activity nano-enzyme and preparation method and application thereof | 青岛农业大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-115960720-A | Microorganisms and methods for producing fatty alcohols of specific length and related compounds | 基因组股份公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115812855-A | Feed additive and feed for improving reproductive capacity of sows and growth performance of piglets and application of feed additive and feed | 中国农业大学 | 2023-03-21 | — | — | CN | disclosed |
| WO-2023023538-A2 | TREATING TISSUE INFLAMMATION | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2023-02-23 | — | — | WO | disclosed |
| US-20020150627-A1 | Composition containing creatine and phosphorus | GENERAL NUTRITION INVESTMENT COMPANY | 2002-10-17 | — | — | US | disclosed |
| EP-0188529-A4 | ELECTROLYTE SOLUTIONS AND IN VITRO USE THEREOF. | VEECH RICHARD L | 1988-12-01 | — | — | EP | disclosed |
| EP-0188529-A1 | ELECTROLYTE SOLUTIONS AND IN VITRO USE THEREOF. | VEECH RICHARD L | 1986-07-30 | — | — | EP | disclosed |
| WO-1986000335-A1 | ELECTROLYTE SOLUTIONS AND IN VITRO USE THEREOF | VEECH RICHARD L | 1986-01-16 | — | — | WO | disclosed |
| US-4361570-A | HUMAN AND VETERINARY MEDICINE | ISTITUTO LUSO FARMACO D'ITALIA S.P.A. (IT) | 1982-11-30 | — | — | US | disclosed |